Monitoring the serum levels of Amikacin, administered once daily, is performed to monitor the optimum drug concentration in the bloodstream. Amikacin is commonly used to treat severe gram-negative infections across various age groups. Healthcare providers employ this test to oversee enhancements in clinical and microbiological outcomes while minimizing the risk of toxicity.